CARLOS
CAMPS HERRERO
EMÉRITO/A UNIVERSIDAD
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (31)
2024
-
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
Cell Communication and Signaling, Vol. 22, Núm. 1
-
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma
Molecular Oncology, Vol. 18, Núm. 1, pp. 190-215
2023
-
A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients
Annals of Surgical Oncology, Vol. 30, Núm. 2, pp. 1225-1235
-
ASO Visual Abstract: A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-small Cell Lung Cancer Patients
Annals of surgical oncology, Vol. 30, Núm. 2, pp. 1238-1239
-
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study
ERJ Open Research, Vol. 9, Núm. 6
-
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 24
-
Clinical and technical insights of tumour mutational burden in non-small cell lung cancer
Critical Reviews in Oncology/Hematology, Vol. 182
2022
-
Capillary and cutaneous hypopigmentation secondary to pazopanib
Medicina Clinica
-
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
BMC Cancer, Vol. 22, Núm. 1
-
Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study
Journal of Nutrition and Metabolism, Vol. 2022
2021
-
3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study
Materials Science and Engineering C, Vol. 122
-
Exosomal microRNAs in non-small cell lung cancer
Translational Cancer Research, Vol. 10, Núm. 6, pp. 3128-3139
-
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888
-
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
Molecular Oncology, Vol. 15, Núm. 9, pp. 2363-2376
-
dPCR application in liquid biopsies: divide and conquer
Expert Review of Molecular Diagnostics, Vol. 21, Núm. 1, pp. 3-15
2020
-
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer
Expert Review of Molecular Diagnostics, Vol. 20, Núm. 6, pp. 575-582
-
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
Translational Lung Cancer Research, Vol. 9, Núm. 4, pp. 1074-1083
-
Development of a multicriteria decision analysis framework for evaluating and positioning oncologic treatments in clinical practice
Journal of Oncology Practice
-
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
Journal of Thoracic Disease, Vol. 12, Núm. 5, pp. 2771-2780
-
Safe neoadjuvant trastuzumab-based treatment in HER2 + inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature
Journal of Oncology Pharmacy Practice, Vol. 26, Núm. 2, pp. 492-495